Aubagio ‘slows brain atrophy in RRMS patients’
Aubagio ‘slows brain atrophy in RRMS patients’
Genzyme has announced results from magnetic resonance imaging (MRI) analysis of participants in the Phase III TEMSO clinical trial showing Aubagio was able to slow the loss of brain volume (or atrophy) versus a placebo over two years in patients with relapsing-remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 11590 Views
-
Last post by accordingnature495
-
- 0 Replies
- 1767 Views
-
Last post by NHE
-
- 0 Replies
- 1447 Views
-
Last post by NHE
-
- 4 Replies
- 1520 Views
-
Last post by NHE
-
- 0 Replies
- 1220 Views
-
Last post by NHE
-
- 0 Replies
- 1552 Views
-
Last post by NHE
-
- 0 Replies
- 2019 Views
-
Last post by frodo
-
- 0 Replies
- 2026 Views
-
Last post by NHE
-
- 0 Replies
- 1660 Views
-
Last post by NHE